Calcium Channel Blocker Reduces Airway Remodeling in Severe Asthma. A Proof-of-Concept Study

Abstract

Gallopamil treatment for 12 months reduces BSM remodeling and prevents the occurrence of asthma exacerbations. Clinical trial registered with www.clinicaltrials.gov (NCT 00896428).